Abstract
Acute anterior uveitis is a relatively common disease of uncertain aetiology. Its association with a wide variety of systemic disorders including ankylosing spondylitis, Reiter's syndrome, Behçet's disease, juvenile rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and sarcoidosis and the prevalence of the HLA antigen B27 (ref. 1) in cases without associated disease have been noted but not explained. In general, animal models for uveitis have not clarified the mechanism of human disease. Most require direct intravitreal injection2 or repeated immunizations with retinal or uveal antigens3. Uveitis does occur in adjuvant arthritis, a syndrome that can be produced in rats by the systemic injection of pepti-doglycan from the cell wall of a variety of Gram-positive bacteria4. The disease, which was initially described following the injection of mycobacteria in mineral oil, has many similarities to Reiter's syndrome5, including the development of eye pathology in as many as 40% of the animals6. As Reiter's syndrome is associated with enteric Gram-negative infections such as Shigella, Salmonella and Yersinia, we sought to produce an arthritis in rats by injecting killed Gram-negative bacteria. Although we have not observed clinical arthritis in these animals, careful histological study has shown the near-universal appearance of uveitis. The studies described below indicate that the eye disease is due to a portion of the bacterial cell wall known as endotoxin or lipopolysaccharide (LPS).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brewerton, D. A., Caffrey, M., Nicholls, A., Waters, D. & James, D. C. O. Lancet ii, 994–996 (1973).
Gamble, C. N., Aronson, S. B. & Brescia, F. B. Archs Ophthal. 84, 321–330 (1970).
Wacker, W. B., Donoso, L. A., Kaslow, C. M., Yankeelov, J. A. & Organisciak, D. T. J. Immun. 119, 1948–1958 (1977).
Kohashi, O., Pearson, C. M., Watanabe, Y., Kotani, S. & Koga, T. J. Immun. 116, 1635–1639 (1976).
Pearson, C. M., Waksman, B. H. & Sharp, J. T. J. exp. Med. 113, 485–510 (1961).
Waksman, B. H. & Bullington, S. J. Archs Ophthal., N.Y. 64, 751–761 (1960).
Calin, A. & Fries, J. F. Ann. int. Med. 84, 564–566 (1976).
Rietschel, E. T. & Galanos, C. Infect. Immun. 15, 34–49 (1977).
Thomas, L. A. Rev. Physiol. 16, 467–490 (1954).
Griesman, S. E. & Hornick, R. B. Trans. Am. clin. clim. Ass. 56, 43–50 (1975).
Woods, A. C. Archs Ophthal. 45, 451–464 (1916).
Berens, C., Angevine, M., Guy, L. & Rothbard, S. Am. J. Ophthal. 21, 1315–1329 (1938).
Rosenow, E. C. & Nickel, A. C. Am. J. Ophthal. 15, 1–18 (1932).
Ayo, C. Proc. Soc. exp. Biol. 47, 500–501 (1941).
Ayo, C. J. Immun. 47, 113–125 (1943).
Howes, E. L., McKay, D. G. & Aronson, S. B. Lab. Invest. 24, 217–228 (1971).
Levene, R. Z. & Breinin, G. M. Archs Ophthal. 61, 568–577 (1969).
Aoki, K. Acta med. okayama 32, 147–158 (1978).
Weissman, G. & Thomas, L. J. exp. Med. 116, 433–450 (1962).
Peeters, T. L., Vantrappen, G. & Geboes, K. Gut 17, 300–305 (1976).
Hayasaka, S., Hara, S. & Mizuno, K. Albrecht v. Graefes Arch. Ophthal. 203, 139–144 (1977).
Dausset, J. & Svejgaard, A. HLA and Disease (INSERM, Paris, 1976).
Ebringer, A., Cowling, P., Ngwa Suh, N., James, D. C. O. & Ebringer, R. W. HLA and Disease, 27 (INSERM, Paris, 1976).
Seager, K., Bashir, H. V., Geczy, A. F., Edmonds, J. & De Vere-Tyndall, A. Nature 277, 68–70 (1979).
Geczy, A. F., Alexander, K., Bushir, H. V. & Edmonds, J. Nature 283, 782–784 (1980).
Ebringer, R., Cadwell, D. & Ebringer, A. Br. med. J. 1, 383 (1979).
Gamble, C. N., Aronson, S. B. & Brescia, F. B. Archs Ophthal. 84, 331–334 (1970).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rosenbaum, J., McDevitt, H., Guss, R. et al. Endotoxin-induced uveitis in rats as a model for human disease. Nature 286, 611–613 (1980). https://doi.org/10.1038/286611a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/286611a0
This article is cited by
-
Transcriptome analysis of AAV-induced retinopathy models expressing human VEGF, TNF-α, and IL-6 in murine eyes
Scientific Reports (2022)
-
The acute phase response protein SERPINA3 is increased in tear fluid from the unaffected eyes of patients with unilateral acute anterior uveitis
Journal of Ophthalmic Inflammation and Infection (2021)
-
Protective effect of filgotinib in rat endotoxin-induced uveitis model
International Ophthalmology (2021)
-
Recent developments in regenerative ophthalmology
Science China Life Sciences (2020)
-
Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development
Pharmaceutical Research (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.